Testing the Effectiveness of Individualized Disease Prevention for Middle-Aged Adults
检验中年个体化疾病预防的有效性
基本信息
- 批准号:10636779
- 负责人:
- 金额:$ 59.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AdherenceAdultAdvisory CommitteesAgeAge FactorsArthritisAsthmaBehaviorBenefits and RisksCharacteristicsChronic DiseaseClinicClinicalClinical ResearchColonoscopyDecision AidElectronic Health RecordEnsureFoundationsGoalsGuidelinesHealthImmunizationIndividualInformation TechnologyInterventionLifeLife ExpectancyLife StyleMammographyMeasuresMedical HistoryMedicineMethodsModelingPatient PreferencesPatientsPersonsPhysiciansPreventionPrevention GuidelinesPreventive carePreventive servicePrintingProcessProviderPublishingQuality of Life AssessmentQuality of lifeQuality-Adjusted Life YearsRaceRecommendationRisk FactorsScreening for cancerServicesStandardizationTestingTimeUnited StatesUnited States Preventative Services Task ForceVisitWeightagedaging populationblood pressure reductioncare deliverycare systemscomorbiditycostdiabeticdisorder preventioneffectiveness testingevidence basehealth care servicehypertensiveimprovedindividualized medicinemathematical modelmiddle agepatient engagementpreventprimary care clinicrandomized trialsexshared decision makingside effectsmoking cessationsuccessful interventiontool
项目摘要
Project Summary/Abstract
This proposal seeks to help middle-aged adults (aged 50-64 y) make an informed decision about the health
care services that are most likely to promote a longer, healthier life. There are currently 26 evidence-based
services to prevent or manage chronic disease in middle-age, but it is difficult to follow them all. Patients need
help to better understand the tradeoffs between services.
To overcome these barriers, we are currently conducting an R21 that identifies the preventive services with the
greatest impact on life expectancy, and engages patients and providers in shared decision-making. Patients
and providers highly value the framework. We also are developing proof-of-concept to access and print the
results in the electronic health record.
This proposal has 3 aims. First, we will adapt a previously-published analytic model to measure the gain in
quality-adjusted life expectancy associated with adherence to 24 of 26 major preventive care services. Results
will be individualized for a patient’s age and risk factors. Second, we will integrate a previously-developed
decision aid with the electronic health record. We will conduct iterative testing to ensure accuracy and
usefulness. Third, we will conduct a randomized trial to test the effectiveness of the decision aid on middle-
aged patient behavior in diverse primary care clinics. During clinical visits, patients and physicians will discuss
the decision aid and engage in shared decision making, to prioritize preventive care goals. We will measure
the change in preventive care utilization between intervention and control patients.
This proposal builds upon our inter-disciplinary team’s strong foundation in clinical research, mathematical
modeling, shared decision-making and information technology. A successful intervention should help to
fundamentally change preventive care delivery in the United States, to maximize health and prevent illness in
the middle-aged population.
项目总结/摘要
该建议旨在帮助中年人(50-64岁)对健康做出明智的决定。
最有可能促进更长寿、更健康生活的护理服务。目前有26个基于证据的
在中年人中,预防或管理慢性病的服务,但很难全部遵循。患者需要
有助于更好地理解服务之间的权衡。
为了克服这些障碍,我们目前正在进行R21,确定预防服务与
对预期寿命的影响最大,并使患者和提供者参与共同决策。患者
供应商高度重视该框架。我们还在开发概念验证,以访问和打印
电子健康记录的结果。
这个建议有三个目的。首先,我们将采用以前发表的分析模型来衡量
质量调整的预期寿命与坚持26项主要预防保健服务中的24项有关。结果
将根据患者的年龄和风险因素进行个体化。其次,我们将整合以前开发的
电子健康记录的决策辅助。我们将进行迭代测试,以确保准确性,
有用性第三,我们将进行一项随机试验,以测试决策辅助工具对中-
不同初级保健诊所的老年患者行为。在临床访问期间,患者和医生将讨论
决策援助和参与共同决策,优先考虑预防保健目标。我们将测量
干预组和对照组患者预防保健利用的变化。
这项建议建立在我们的跨学科团队在临床研究,数学,
建模、共享决策和信息技术。成功的干预措施应有助于
从根本上改变美国的预防保健服务,以最大限度地提高健康和预防疾病,
中年人口。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Personalized Disease Prevention (PDP): study protocol for a cluster-randomized clinical trial.
个性化疾病预防(PDP):集群随机临床试验的研究方案。
- DOI:10.1186/s13063-022-06750-7
- 发表时间:2022-10-22
- 期刊:
- 影响因子:2.5
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Glen Taksler其他文献
Glen Taksler的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Glen Taksler', 18)}}的其他基金
Testing the Effectiveness of Individualized Disease Prevention for Middle-Aged Adults
检验中年个体化疾病预防的有效性
- 批准号:
10177833 - 财政年份:2019
- 资助金额:
$ 59.23万 - 项目类别:
Testing the Effectiveness of Individualized Disease Prevention for Middle-Aged Adults
检验中年个体化疾病预防的有效性
- 批准号:
10175863 - 财政年份:2019
- 资助金额:
$ 59.23万 - 项目类别:
Testing the Effectiveness of Individualized Disease Prevention for Middle-Aged Adults
检验中年个体化疾病预防的有效性
- 批准号:
10398138 - 财政年份:2019
- 资助金额:
$ 59.23万 - 项目类别:
Testing the Effectiveness of Individualized Disease Prevention for Middle-Aged Adults
检验中年个体化疾病预防的有效性
- 批准号:
10671243 - 财政年份:2019
- 资助金额:
$ 59.23万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 59.23万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 59.23万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 59.23万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 59.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 59.23万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 59.23万 - 项目类别:
Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
- 批准号:
2230829 - 财政年份:2023
- 资助金额:
$ 59.23万 - 项目类别:
Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 59.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 59.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 59.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)